Measuring collagen degradation
- 1 June 1993
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 23 (6) , 339-340
- https://doi.org/10.1111/j.1365-2362.1993.tb02033.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Factors affecting the assay of urinary 3–hydroxy pyridiniurn crosslinks of collagen as markers of bone resorptionEuropean Journal of Clinical Investigation, 1993
- Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradationClinical Chemistry, 1993
- Assay of pyridinium crosslinks in serum using narrow-bore ion-paired reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urineJournal of Bone and Mineral Research, 1992
- Urinary pyridinium crosslinks of collagen Specific markers of bone resorption in metabolic bone diseaseTrends in Endocrinology & Metabolism, 1992
- Radioimmunoassay of type I collagen that mainly detects degradation products in serum: application to patients with liver diseasesClinical Chemistry, 1990
- An enzyme-linked immunoassay for the collagen cross-link pyridinolineBiochemical Journal, 1982